Probiotic Visbiome for Inflammation and Translocation in HIV Ι (PROOV IT I)
Probiotic Visbiome for Inflammation and Translocation in HIV I (PROOV IT I)
Sponsor: CIHR Canadian HIV Trials Network
Terminated
Recruitment potential impaired by shift in clinical care whereby practically all HIV patients receive standard treatment as soon as possible after HIV diagnosis
Other terminated trials from CIHR Canadian HIV Trials Network
This PHASE2 trial investigates HIV-1 Infection and is currently terminated or withdrawn. CIHR Canadian HIV Trials Network leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE2
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2
-
Mar 2018 — May 2018 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jan 2017 — Mar 2018 [monthly]
Recruiting PHASE2
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CIHR Canadian HIV Trials Network
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .